<qa>  What is the name of the immunotherapy that is used in the last 1 month prior to enrollmentActive tuberculosis Autoimmune disorders Severe chronic inflammatory diseases History of anaphylactic reactions Specific immunotherapy 3 years Simultaneous participation in other clinical trials Serious acute or chronic organic disease or mental disorder Congenital nasal abnormalities Pregnancy or breast feeding Blood coagulation disorder andor current use of anticoagulants Allergy desensitisation therapy current, during the past two years, or planned in the next two years Previous systemically administered corticosteroids, antihistamines, or decongestants in the last 1 months prior to enrollment 